4.6 Article

Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men

Journal

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpendo.00429.2014

Keywords

glucagon-like peptide-1; blood pressure; heart rate; cardiac output; renal plasma flow

Funding

  1. Danish Heart Foundation
  2. Board of Research of Bispebjerg University Hospital
  3. Arvid Nilssons Foundation
  4. Torben and Alice Frimodts Foundation
  5. Dagmar Marshalls Foundation
  6. Helen and Ejnar Bjornows Foundation
  7. Jens Anker Andersen Foundation
  8. Waagens Foundation
  9. Else and Mogens Wedellsborgs Fond
  10. Snedkermester Sophus Jacobsen and hustru Astrid Jacobsens Foundation
  11. NNF Center for Basic Metabolic Research [Holst Group] Funding Source: researchfish

Ask authors/readers for more resources

The present experiments were performed to elucidate the acute effects of intravenous infusion of glucagon-like peptide (GLP)-1 on central and renal hemodynamics in healthy men. Seven healthy middle-aged men were examined on two different occasions in random order. During a 3-h infusion of either GLP-1 (1.5 pmol.kg(-1).min(-1)) or saline, cardiac output was estimated noninvasively, and intraarterial blood pressure and heart rate were measured continuously. Renal plasma flow, glomerular filtration rate, and uptake/release of hormones and ions were measured by Fick's Principle after catheterization of a renal vein. Subjects remained supine during the experiments. During GLP-1 infusion, both systolic blood pressure and arterial pulse pressure increased by 5 +/- 1 mmHg (P = 0.015 and P = 0.002, respectively). Heart rate increased by 5 +/- 1 beats/min (P = .005), and cardiac output increased by 18% (P = 0.016). Renal plasma flow and glomerular filtration rate as well as the clearance of Na+ and Li+ were not affected by GLP-1. However, plasma renin activity decreased (P = 0.037), whereas plasma levels of atrial natriuretic peptide were unaffected. Renal extraction of intact GLP-1 was 43% (P < 0.001), whereas 60% of the primary metabolite GLP-1 9-36amide was extracted (P = 0.017). In humans, an acute intravenous administration of GLP-1 leads to increased cardiac output due to a simultaneous increase in stroke volume and heart rate, whereas no effect on renal hemodynamics could be demonstrated despite significant extraction of both the intact hormone and its primary metabolite.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available